ANIX
Anixa Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.07
+0.66%Jun 29, 2026, 12:45 UTC
Anixa Biosciences was granted a Korean patent for its breast cancer vaccine by the Korean Ministry of Intellectual Property, extending protection through 2040.
Source:Jun 1, 2026, 13:00 UTC
Anixa Biosciences received a Notice of Allowance from the Canadian Intellectual Property Office for a patent covering its ovarian cancer vaccine technology.
Source: